노인성 우울증과 알츠하이머병의 관계 - 아밀로이드 이론을 바탕으로

키워드

참고문헌 (128)

1. Christensen H, "A quantitative review of cognitive deficits in depression and Alzheimer-type dementia", J Int Neuropsychol Soc, 3, pp.631~651 (1997)
2. Steffens DC, "Geriatric depression and cognitive impairment", Psychol Med, 38, pp.163~175 (2008)
3. Zubenko GS, "A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease", Am J Psychiatry, 160, pp.857~866 (2003)
4. Mehta KM, "Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults", J Gerontol A Biol Sci Med Sci, 58, pp.M461~M467 (2003)
5. Arve S, "Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts", Aging (Milano), 11, pp.90~95 (1999)
6. Barnes DE, "The projected effect of risk factor reduction on Alzheimer’s disease prevalence", Lancet Neurol, 10, pp.819~828 (2011)
7. Jorm AF, "History of depression as a risk factor for dementia:an updated review", Aust N Z J Psychiatry, 35, pp.766~781 (2001)
8. Ownby RL, "Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis", Arch Gen Psychiatry, 63, pp.530~538 (2006)
9. Panza F, "Late-life depression, mild cognitive impairment, and dementia: possible continuum?", Am J Geriatr Psychiatry, 18, pp.98~116 (2010)
10. 김병수, "다시 보는 알츠하이머병의 아밀로이드 가설", 생물치료정신의학, 20(3), pp.173~186 (2014), 대한생물치료정신의학회
11. Hardy JA, "Alzheimer’s disease: the amyloid cascade hypothesis", Science, 256, pp.184~185 (1992)
12. Herholz K, "Clinical amyloid imaging in Alzheimer’s disease", Lancet Neurol, 10, pp.667~670 (2011)
13. Villemagne VL, "Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias", J Nucl Med, 52, pp.1210~1217 (2011)
14. Chung JK, "Lifetime history of depression predicts increased amyloid-beta accumulation in patients with mild cognitive impairment", J Alzheimers Dis, 49, pp.1189~1190 (2015)
15. Harrington KD, "Amyloidbeta and depression in healthy older adults: a systematic review", Aust N Z J Psychiatry, 49, pp.36~46 (2015)
16. Lavretsky H, "Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults", Am J Geriatr Psychiatry, 17, pp.493~502 (2009)
17. PiB binding, "Neurobiol Aging", 2012, 23342342~
18. florbetapir in geriatric depression: early-onset versus late-onset, "Int J Geriatr Psychiatry", 2015, 720~728
19. Wu KY, "Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir(AV-45", Amyvid) positron emission tomography, 2014, pp.41, 714~722
20. Butters MA, "Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B", Alzheimer Dis Assoc Disord, 22, pp.261~268 (2008)
21. Zakzanis KK, "On the nature and pattern of neurocognitive function in major depressive disorder", Neuropsychiatry Neuropsychol Behav Neurol, 11, pp.111~119 (1998)
22. Marazziti D, "Cognitive impairment in major depression", Eur J Pharmacol, 626, pp.83~86 (2010)
23. Nebes RD, "Decreased working memory and processing speed mediate cognitive impairment in geriatric depression", Psychol Med, 30, pp.679~691 (2000)
24. Beats BC, "Cognitive performance in tests sensitive to frontal lobe dysfunction in the el-derly depressed", Psychol Med, 26, pp.591~603 (1996)
25. Austin MP, "Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?", Psychol Med, 29, pp.73~85 (1999)
26. Harvey PO, "Cognitive control and brain resources in major depression: an fMRI study using the n-back task", Neuroimage, 26, pp.860~869 (2005)
27. Olin JT, "Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background", Am J Geriatr Psychiatry, 10, pp.129~141 (2002)
28. McDermott LM, "A meta-analysis of depression severity and cognitive function", J Affect Disord, 119, pp.1~8 (2009)
29. Feil D, "Apathy and cognitive performance in older adults with depression", Int J Geriatr Psychiatry, 18, pp.479~485 (2003)
30. Miller BL, "Cognitive functioning in older depressed outpatients: relationship of presence and severity of depression to neuropsychological test scores", Neuropsychology, 9 (1995)
31. Mormont C, "The influence of age and depression on intellectual and memory performances", Acta Psychiatr Belg, 84, pp.127~134 (1984)
32. Savard RJ, "Halstead-Reitan Category Test in bipolar and unipolar affective disorders. Relationship to age and phase of illness", J Nerv Ment Dis, 168, pp.297~304 (1980)
33. Pisljar M, "Executive dysfunction in late-onset depression", Psychiatr Danub, 20, pp.231~235 (2008)
34. Herrmann LL, "The cognitive neuropsychology of depression in the elderly", Psychol Med, 37, pp.1693~1702 (2007)
35. Basso MR, "Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task", Neuropsychology, 13, pp.557~563 (1999)
36. Hammar A, "Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study", Psychiatry Res, 118, pp.189~196 (2003)
37. Schmand B, "Subjective memory complaints in the elderly: depressive symptoms and future dementia", Br J Psychiatry, 171, pp.373~376 (1997)
38. Bartolini M, "Motivational symptoms of depression mask preclinical Alzheimer’s disease in elderly subjects", Dement Geriatr Cogn Disord, 19, pp.31~36 (2005)
39. Starkstein SE, "Syndromic validity of apathy in Alzheimer’s disease", Am J Psychiatry, 158, pp.872~877 (2001)
40. Stella F, "Neurobiological correlates of apathy in Alzheimer’s disease and mild cognitive impairment: a critical review", J Alzheimers Dis, 39, pp.633~648 (2014)
41. Marshall GA, "Positron emission tomography metabolic correlates of apathy in Alzheimer disease", Arch Neurol, 64, pp.1015~1020 (2007)
42. Donovan NJ, "Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum", Am J Geriatr Psychiatry, 22, pp.1168~1179 (2014)
43. Jonsson M, "Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia", Int J Geriatr Psychiatry, 25, pp.588~595 (2010)
44. Cacciari C, "White matter microstructure and apathy level in amnestic mild cognitive impairment", J Alzheimers Dis, 20, pp.501~507 (2010)
45. Munro CE, "Neuropsychiatric symptoms and functional connectivity in mild cognitive impairment", J Alzheimers Dis, 46, pp.727~735 (2015)
46. Geda YE, "Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study", Am J Psychiatry, 171, pp.572~581 (2014)
47. Donovan NJ, "Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease", Am J Geriatr Psychiatry, 22, pp.1642~1651 (2014)
48. Modrego PJ, "Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study", Arch Neurol, 61, pp.1290~1293 (2004)
49. Ismail Z, "Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional di-agnostic criteria for mild behavioral impairment", Alzheimers Dement (2015)
50. David ND, "Trajectories of neuropsychiatric symptoms and cognitive decline in mild cognitive impairment", Am J Geriatr Psychiatry, 24, pp.70~80 (2016)
51. Palmer K, "Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy", J Alzheimers Dis, 20, pp.175~183 (2010)
52. Jessen F, "Prediction of dementia in primary care patients", PLoS One, 6, pp.e16852~ (2011)
53. Jessen F, "AD dementia risk in late MCI, in early MCI, and in subjective memory impairment", Alzheimers Dement, 10, pp.76~83 (2014)
54. Belleville S, "Detecting early preclinical Alzheimer’s disease via cognition, neuropsychiatry, and neuroimaging:qualitative review and recommendations for testing", J Alzheimers Dis, 42(Suppl 4), pp.S375~S382 (2014)
55. Petkus AJ, "Anxiety is associated with increased risk of dementia in older Swedish twins", Alzheimers Dement (2015)
56. Lobo A, "Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer’s type", Neurotox Res, 14, pp.263~272 (2008)
57. Li JQ, "Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies", J Neurol Neurosurg Psychiatry (2015)
58. Beydoun MA, "Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis", Obes Rev, 9, pp.204~218 (2008)
59. Murray J, "FDG and Amyloid PET in cognitively normal individuals at risk for late-onset Alzheimer’s disease", Adv J Mol Imaging, 4, pp.15~26 (2014)
60. Ivanoiu A, "Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease", J Neurol, 252, pp.47~55 (2005)
61. Loewenstein DA, "Semantic interference deficits and the detection of mild Alzheimer’s disease and mild cognitive impairment without dementia", J Int Neuropsychol Soc, 10, pp.91~100 (2004)
62. Hudon C, "The assessment of recognition memory using the Remember", Know procedure in amnestic mild cognitive impairment and probable Alzheimer’s disease, 2009, pp.70, 171~179
63. Villeneuve S, "The nature of memory failure in mild cognitive impairment: examining association with neurobiological markers and effect of progression", Neurobiol Aging, 33, pp.1967~1978 (2012)
64. Belleville S, "Working memory and control of attention in persons with Alzheimer’s disease and mild cognitive impairment", Neuropsychology, 21, pp.458~469 (2007)
65. Gagnon LG, "Working memory in mild cognitive impairment and Alzheimer’s disease: contribution of forgetting and predictive value of complex span tasks", Neuropsychology, 25, pp.226~236 (2011)
66. Rainville C, "Executive function deficits in persons with mild cognitive impairment: a study with a Tower of London task", J Clin Exp Neuropsychol, 34, pp.306~324 (2012)
67. Dannhauser TM, "The functional anatomy of divided attention in amnestic mild cognitive impairment", Brain, 128, pp.1418~1427 (2005)
68. Belleville S, "Task switching capacities in persons with Alzheimer’s disease and mild cognitive impairment", Neuropsychologia, 46, pp.2225~2233 (2008)
69. Lehrner J, "Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing", Wien Klin Wochenschr, 117, pp.629~635 (2005)
70. Devanand DP, "Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease", Behav Neurol, 64, pp.871~879 (2008)
71. Sarazin M, "Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study", Neurology, 69, pp.1859~1867 (2007)
72. Hänninen T, "A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia", J Am Geriatr Soc, 43, pp.1007~1015 (1995)
73. Peters F, "Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors", J Alzheimers Dis, 38, pp.307~318 (2014)
74. Rabin LA, "Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer’s disease", Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 16, pp.357~376 (2009)
75. Eckerström C, "A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia", J Alzheimers Dis, 36, pp.421~431 (2013)
76. Tierney MC, "Prediction of probable Alzheimer’s disease in memory-impaired patients: A prospective longitudinal study", Neurology, 46, pp.661~665 (1996)
77. Galton CJ, "A comparison of the Addenbrooke’s Cognitive Examination(ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer’s disease", Cogn Behav Neurol, 18, pp.144~150 (2005)
78. Didic M, "Impaired visual recognition memory predicts Alzheimer’s disease in amnestic mild cognitive impairment", Dement Geriatr Cogn Disord, 35, pp.291~299 (2013)
79. Guarch J, "Mild cognitive impairment: A risk indicator of later dementia, or a preclinical phase of the disease?", Int J Geriatr Psychiatry, 23, pp.257~265 (2008)
80. Espinosa A, "A longitudinal followup of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved", J Alzheimers Dis, 34, pp.769~780 (2013)
81. Ewers M, "Prediction of conversion from mild cognitive impairment to Alzheimer’s disease dementia based upon biomarkers and neuropsychological test performance", Neurobiol Aging, 33, pp.1203~1214 (2012)
82. Albert MS, "Preclinical prediction of AD using neuropsychological tests", J Int Neuropsychol Soc, 7, pp.631~639 (2001)
83. Griffith HR, "Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period", J Int Neuropsychol Soc, 12, pp.166~175 (2006)
84. Belleville S, "Predicting decline in mild cognitive impairment:a prospective cognitive study", Neuropsychology, 28, pp.643~652 (2014)
85. Artero S, "Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal stud", Acta Psychiatr Scand, 107, pp.390~393 (2003)
86. Jungwirth S, "Prediction of Alzheimer dementia with short neuropsychological instruments", J Neural Transm, 116, pp.1513~1521 (2009)
87. Harper L, "An algorithmic approach to structural imaging in dementia", J Neurol Neurosurg Psychiatry, 85, pp.692~698 (2014)
88. Duara R, "Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease", Neurology, 71, pp.1986~1992 (2008)
89. Frisoni GB, "The clinical use of structural MRI in Alzheimer disease", Nat Rev Neurol, 6, pp.67~77 (2010)
90. Hua X, "Tensor-based morphometry as a neuroimaging biomarker for Alzheimer’s disease: An MRI study of 676 AD, MCI, and normal subjects", Neuroimage, 43, pp.458~469 (2008)
91. Desikan RS, "Automated MRI measures predict progression to Alzheimer’s disease", Neurobiol Aging, 31, pp.1364~1374 (2010)
92. Kovacevic S, "Highthroughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive Impairment", Alzheimer Dis Assoc Disord, 23, pp.139~145 (2009)
93. Risacher SL, "Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort", Curr Alzheimer Res, 6, pp.347~361 (2009)
94. Walhovd KB, "Combining MR imaging, Positron-Emission Tomography, and CSF Biomarkers in the diagnosis and prognosis of Alzheimer disease", Am J Neuroradiol, 31, pp.347~354 (2010)
95. Chou YY, "Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer’s disease, mild cognitive impairment and elderly controls", Neuroimage, 46, pp.394~410 (2009)
96. Chou YY, "Ventricular maps in 804 ADNI subjects:correlations with CSF biomarkers and clinical decline", Neurobiol Aging, 31, pp.1386~1400 (2010)
97. Madsen SK, "3D maps localize caudate nucleus atrophy in 400 Alzheimer’s disease, mild cognitive impairment, and healthy elderly subjects", Neurobiol Aging, 31, pp.1312~1325 (2010)
98. Chen KW, "Characterizing Alzheimer’s disease using a hypometabolic convergence index", Neuroimage, 56, pp.52~60 (2011)
99. Hardy J, "The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics", Science, 297, pp.353~356 (2002)
100. Thal DR, "Phases of A -deposition in the human brain and its relevance for the development of AD", Neurology, 58, pp.1791~1800 (2002)
101. Brilliant MJ, "The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer’s disease", Neuropathol Appl Neurobiol, 23, pp.322~325 (1997)
102. Doraiswamy PM, "Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study", Mol Psychiatry, 19, pp.1044~1051 (2014)
103. Pike KE, "Cognition and beta-amyloid in preclinical Alzheimer’s disease: data from the AIBL study", Neuropsychologia, 49, pp.2384~2390 (2011)
104. F 18), "J Nucl Med", 2010, 913~920
105. Camus V, "Using PET with 18F-AV-45 (florbetapir)to quantify brain amyloid load in a clinical environment", Eur J Nucl Med Mol Imaging, 39, pp.621~631 (2012)
106. AV-45 positron emission tomography in Chinese population, "PLoS One", 2013, e58974~
107. Rabinovici GD, "Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo", Behav Neurol, 21, pp.117~128 (2009)
108. Rowe CC, "Imaging beta-amyloid burden in aging and dementia", Neurology, 68, pp.1718~1725 (2007)
109. flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer’s disease: specific detection of advanced phases of amyloid-β pathology, "Alzheimers Dement", 2015, 975~985
110. Braak H, "Frequency of stages of Alzheimerrelated lesions in different age categories", Neurobiol Aging, 18, pp.351~357 (1997)
111. Bassuk SS, "Depressive symptomatology and incident cognitive decline in an elderly community sample", Arch Gen Psychiatry, 55, pp.1073~1081 (1998)
112. Kropiunigg U, "Psychosocial risk factors for Alzheimer’s disease", Psychother Psychosom Med Psychol, 49, pp.153~159 (1999)
113. Sapolsky RM, "The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis", Endocr Rev, 7, pp.284~301 (1986)
114. Green RC, "Depression as a risk factor for Alzheimer disease: the MIRAGE Study", Arch Neurol, 60, pp.753~759 (2003)
115. Gracia-García P, "Depression and incident Alzheimer disease: the impact of disease severity", Am J Geriatr Psychiatry, 23, pp.119~129 (2015)
116. Koenig AM, "Cognition in late life depression:Treatment Considerations", Curr Treat Options Psychiatry, 1, pp.1~14 (2014)
117. Berger AK, "The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study", Neurology, 53, pp.1998~2002 (1999)
118. Geerlings MI, "Depressive symptoms and risk of Alzheimer’s disease in more highly educated older people", J Am Geriatr Soc, 48, pp.1092~1097 (2000)
119. Lavretsky H, "Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults", Am J Geriatr Psychiatry, 17, pp.493~502 (2009)
120. Wu K-YY, "Increased brain amyloid deposition in patients with a lifetime history of major depression:evidenced on 18F-florbetapir(AV-45", Amyvid)positron emission tomography, 2014, pp.41, 714~722
121. F 18), "Journal of nuclear medicine: official publication, Society of Nuclear Medicine", 2010, 913~920
122. Camus V, "Using PET with 18F-AV-45 (florbetapir)to quantify brain amyloid load in a clinical environment", European journal of nuclear medicine and molecular imaging, 39, pp.621~631 (2012)
123. AV-45 positron emission tomography in Chinese population, "PloS One", 2013, ~
124. Green KN, "Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease", J Neurosci, 26, pp.9047~9056 (2006)
125. Kang J-EE, "Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity", Proc Nati Acad Sci USA, 104, pp.10673~10678 (2007)
126. florbetapir in geriatric depression: early-onset versus lateonset, "Int J Geriatr Psychiatry", 2015, 720~728
127. Chung JK, "Lifetime history of depression predicts increased amyloid-beta accumulation in patients with mild cognitive impairment", J Alzheimers Dis, 45, pp.907~919 (2015)
128. Brendel M, "Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients", Eur J Nucl Med Mol Imaging, 42, pp.716~724 (2015)

관련 논문AI추천